ArriVent BioPharma, Inc. (AVBP) Misses Q1 EPS by 117c
Tweet
Share
E-mailGet Alerts AVBP Hot Sheet
Join SI Premium – FREE
ArriVent BioPharma, Inc. (NASDAQ: AVBP) reported Q1 EPS of ($1.90), $1.17 worse than the analyst estimate of ($0.73).
For earnings history and earnings-related data on ArriVent BioPharma, Inc. (AVBP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance
- Broadcom (AVGO) Tops Q2 EPS by 5c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
